AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34062085 — intervention group
Group type: COMPARATOR
Intervention: Control yogurt
Number of subjects: 136
Study 33517881 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tourniquet group (Group B)
Number of subjects: 150
Study 33517881 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet group (Group A)
Number of subjects: 150
Study 33517881 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet in cementation group (Group C)
Number of subjects: 150
Study 32341486 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-reduced bread and dietary counseling (Intervention B)
Number of subjects: 309
Study 32341486 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-reduced bread (Intervention A)
Number of subjects: 309
Study 32341486 — intervention group
Group type: COMPARATOR
Intervention: Regular sodium bread (Control)
Number of subjects: 309
Study 36027906 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 144
Study 36027906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 33673867 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine specialist
Number of subjects: 1368
Study 33673867 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine non-specialist
Number of subjects: 1368
Study 33673867 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person specialist
Number of subjects: 1368
Study 33673867 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person non-specialist
Number of subjects: 1368
Study 33673867 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 1368
Study 36119147 — intervention group
Group type: EXPERIMENTAL
Intervention: Two envelopes method of teaching
Number of subjects: 120
Study 36119147 — intervention group
Group type: COMPARATOR
Intervention: Lecture hall format (2018)
Number of subjects: 120
Study 33277285 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF + CA/CY/TBI
Number of subjects: 160
Study 33277285 — intervention group
Group type: COMPARATOR
Intervention: CA/CY/TBI
Number of subjects: 160
Study 34992119 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional cash transfers (CCTs) of US$4.5
Number of subjects: 5444
Study 34992119 — intervention group
Group type: COMPARATOR
Intervention: Phone credit of US$0.5
Number of subjects: 5444
Study 34255420 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 349
Study 34255420 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 349
Study 35489309 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuum beliefs intervention
Number of subjects: 304
Study 35489309 — intervention group
Group type: COMPARATOR
Intervention: Perceived differences from a person with depression
Number of subjects: 304
Study 35489309 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressed continuum beliefs
Number of subjects: 304
Study 33788456 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication (flunarizine hydrochloride capsule 10 mg/day)
Number of subjects: 120
Study 33788456 — intervention group
Group type: COMPARATOR
Intervention: Medication (flunarizine hydrochloride capsule 10 mg/day)
Number of subjects: 120
Study 35609291 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive physical therapy (twice daily coached breathing exercises for 2 days and 30 minutes of daily supervised rehabilitation over the first 5 postoperative days)
Number of subjects: 50
Study 35609291 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study 33761894 — intervention group
Group type: COMPARATOR
Intervention: IT morphine 0.2 mg with sham QLB (Group IT)
Number of subjects: 80
Study 33761894 — intervention group
Group type: EXPERIMENTAL
Intervention: IT morphine 0.2 mg and bilateral QLB with 0.25% bupivacaine 25 ml in each side (Group IT+QLB)
Number of subjects: 80
Study 33761894 — intervention group
Group type: COMPARATOR
Intervention: Bilateral QLB with 0.25% bupivacaine 25 ml in each side (Group QLB)
Number of subjects: 80
Study 34082300 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure (SMBP)
Number of subjects: 154
Study 34520536 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy before aerobic exercises, three sessions per week for 12 weeks
Number of subjects: 60
Study 34520536 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercises three times weekly for 12 weeks (Control group)
Number of subjects: 60
Study 34570156 — intervention group
Group type: EXPERIMENTAL
Intervention: Free gingival graft (FGG)
Number of subjects: 16
Study 34570156 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen-matrix xenograft (CMX)
Number of subjects: 16
Study 34570156 — intervention group
Group type: COMPARATOR
Intervention: Deproteinized bovine bone graft (DBBG)
Number of subjects: 16
Study 32329742 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game intervention
Number of subjects: 82
Study 32329742 — intervention group
Group type: COMPARATOR
Intervention: Control group (brochure about food pyramid)
Number of subjects: 82
Study 35764103 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% to 30% SF6 gas tamponade
Number of subjects: 144
Study 35764103 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (BSS)
Number of subjects: 144
Study 32621368 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth opioid recovery support (YORS)
Number of subjects: 41
Study 32621368 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 41
Study 35328014 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of aspirin
Number of subjects: 861
Study 35328014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 861
Study 34118282 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ppm fluoride toothpaste with sodium trimetaphosphate, xylitol, and erythritol (200F-TMP-XE)
Number of subjects: 14
Study 34118282 — intervention group
Group type: EXPERIMENTAL
Intervention: 1100 ppm fluoride toothpaste (1100F)
Number of subjects: 14
Study 34118282 — intervention group
Group type: EXPERIMENTAL
Intervention: 16% Xylitol and 4% Erythritol (XE)
Number of subjects: 14
Study 34118282 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no fluoride, TMP, or XE)
Number of subjects: 14
Study 34118282 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ppm fluoride toothpaste (200F)
Number of subjects: 14
Study 32143732 — intervention group
Group type: EXPERIMENTAL
Intervention: Active peripheral nerve stimulation of the axillary nerve of the affected shoulder
Number of subjects: 0
Study 32143732 — intervention group
Group type: COMPARATOR
Intervention: Sham peripheral nerve stimulation of the axillary nerve of the affected shoulder (Control)
Number of subjects: 0
Study 35766558 — intervention group
Group type: EXPERIMENTAL
Intervention: PN with iron sucrose 100 μg/kg/d (Iron-1)
Number of subjects: 100
Study 35766558 — intervention group
Group type: EXPERIMENTAL
Intervention: PN with iron sucrose 200 μg/kg/d (Iron-2)
Number of subjects: 100
Study 35766558 — intervention group
Group type: EXPERIMENTAL
Intervention: PN with iron sucrose 300 μg/kg/d (Iron-3)
Number of subjects: 100
Study 35766558 — intervention group
Group type: EXPERIMENTAL
Intervention: PN with iron sucrose 400 μg/kg/d (Iron-4)
Number of subjects: 100
Study 35766558 — intervention group
Group type: COMPARATOR
Intervention: Control group (PN without iron sucrose, Iron-0)
Number of subjects: 100
Study 33940550 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion (SC) intervention
Number of subjects: 151
Study 33940550 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance-based (DB) intervention
Number of subjects: 151
Study 33940550 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (WL) control
Number of subjects: 151
Study 34695232 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg vaginal misoprostol
Number of subjects: 76
Study 34695232 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 μg vaginal misoprostol
Number of subjects: 76
Study 33559272 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation with oral polyethylene glycol (PEG) solution
Number of subjects: 144
Study 33559272 — intervention group
Group type: COMPARATOR
Intervention: Liquid diet on the preoperative day
Number of subjects: 144
Study 33559272 — intervention group
Group type: COMPARATOR
Intervention: Minimal residue diet for 3 days
Number of subjects: 144
Study 35165727 — intervention group
Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate 200 mg once daily for 6 days (3 days orally and 3 days intravenously)
Number of subjects: 14
Study 35165727 — intervention group
Group type: COMPARATOR
Intervention: Control group (LPS 2 ng/kg body weight without tedizolid)
Number of subjects: 14
Study 33472259 — intervention group
Group type: EXPERIMENTAL
Intervention: Spacer Block Tool (SBT) used for joint line (JL) reconstruction in Group 2
Number of subjects: 45
Study 33472259 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods for joint line (JL) reconstruction in Group 1
Number of subjects: 45
Study 34022796 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan (20 mg/day)
Number of subjects: 168
Study 34022796 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole (30 mg/day)
Number of subjects: 168
Study 34022796 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Number of subjects: 168
Study 34022796 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole
Number of subjects: 168
Study 32422956 — intervention group
Group type: EXPERIMENTAL
Intervention: 52 mL/day of EVOO
Number of subjects: 149
Study 32422956 — intervention group
Group type: EXPERIMENTAL
Intervention: DieTBra
Number of subjects: 149
Study 32422956 — intervention group
Group type: EXPERIMENTAL
Intervention: DieTBra + 52 mL/day of EVOO
Number of subjects: 149
Study 33530693 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational Video
Number of subjects: 77
Study 33530693 — intervention group
Group type: COMPARATOR
Intervention: Standard Verbal Consent
Number of subjects: 77
Study 32865608 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional multiple-choice questions accompanying lectures
Number of subjects: 675
Study 32865608 — intervention group
Group type: COMPARATOR
Intervention: Supplementary online material only
Number of subjects: 675
Study 34455213 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 international units)
Number of subjects: 34
Study 32543439 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilayer Perceptron model for SMS reply triage
Number of subjects: 3118
Study 32543439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensemble model for SMS reply triage
Number of subjects: 3118
Study 32543439 — intervention group
Group type: EXPERIMENTAL
Intervention: OneVsRest model for 12-category classification
Number of subjects: 3118
Study 32976085 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 46
Study 32976085 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy (COT)
Number of subjects: 46
Study 35908159 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion (CIV) of enoxaparin 40 mg per day for 72 hours
Number of subjects: 40
Study 35908159 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous bolus (SCB) injection of enoxaparin 40 mg per day for 72 hours
Number of subjects: 40
Study 35908159 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CIV and SCB administration of enoxaparin after 72 hours
Number of subjects: 40
Study 34783727 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration therapy (amplitude of 3mm, frequency of 20Hz, 12 sessions, 5 bouts of 120 seconds with 60s rest intervals, 6 days/week for 2 weeks)
Number of subjects: 64
Study 34783727 — intervention group
Group type: COMPARATOR
Intervention: Routine physiotherapy (12 sessions)
Number of subjects: 64
Study 32868548 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective pharmacist verification process on all ED discharge prescriptions
Number of subjects: 750
Study 32868548 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 750
Study 36067740 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic Conditioning (IC)
Number of subjects: 43
Study 36067740 — intervention group
Group type: COMPARATOR
Intervention: IC Sham
Number of subjects: 43
Study 32613244 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum‐formed retainer (VFR) in the mandible (n = 52)
Number of subjects: 104
Study 32613244 — intervention group
Group type: COMPARATOR
Intervention: Bonded cuspid‐to‐cuspid retainers (CTC) (n = 52)
Number of subjects: 104
Study 32613244 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (VFR and CTC)
Number of subjects: 104
Study 34968373 — intervention group
Group type: EXPERIMENTAL
Intervention: Full vaccination with Pfizer-BioNTech vaccine (2 doses, ≥14 days after the second dose)
Number of subjects: 243
Study 34968373 — intervention group
Group type: COMPARATOR
Intervention: Partially vaccinated (1 dose or 2 doses <14 days)
Number of subjects: 243
Study 34968373 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated
Number of subjects: 243
Study 33339768 — intervention group
Group type: EXPERIMENTAL
Intervention: TEZ/IVA
Number of subjects: 144
Study 33339768 — intervention group
Group type: COMPARATOR
Intervention: IVA
Number of subjects: 144
Study 33332232 — intervention group
Group type: EXPERIMENTAL
Intervention: Full body photobiomodulation therapy (PBMT) with a dose of 6.9 J/cm2, irradiance of 46.17 mW/cm2, 5 min irradiation
Number of subjects: 13
Study 33332232 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 13
Study 35226113 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) following standard epineural nerve repair
Number of subjects: 74
Study 35226113 — intervention group
Group type: COMPARATOR
Intervention: Standard epineural nerve repair without HBOT
Number of subjects: 74
Study 35758652 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvratoxumab (monoclonal antibody targeting S. aureus alpha-toxin)
Number of subjects: 720
Study 35758652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 720
Study 32165554 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential (C) spread
Number of subjects: 124
Study 33150590 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg for 3 days)
Number of subjects: 70
Study 33150590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 33980220 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of webcams in NICUs
Number of subjects: 730
Study 33547713 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic positive airway pressure
Number of subjects: 50
Study 33547713 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure
Number of subjects: 50
Study 36375643 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide therapy
Number of subjects: 0
Study 36375643 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (RYGB or SG)
Number of subjects: 0
Study 36375643 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (RYGB)
Number of subjects: 0
Study 36375643 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (SG)
Number of subjects: 0
Study 36375643 — intervention group
Group type: COMPARATOR
Intervention: Bariatric surgery vs. liraglutide therapy
Number of subjects: 0
Study 33103229 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse methylprednisolone therapy (30 mg/kg/d for five days followed by oral steroids 1 mg/kg tapered over 5-6 weeks)
Number of subjects: 44
Study 33103229 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular adrenocorticotropic hormone (ACTH) therapy
Number of subjects: 44
Study 33103229 — intervention group
Group type: COMPARATOR
Intervention: ACTH therapy
Number of subjects: 44
Study 32423392 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF) - cow's milk based infant formula with DHA (17 mg/100 kcal) and ARA (25 mg/100 kcal); 1.9 g protein/100 kcal; 1.2 mg Fe/100 kcal
Number of subjects: 540
Study 32423392 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental formula (EF) - similar infant formula with added source of bovine MFGM (whey protein-lipid concentrate)
Number of subjects: 540
Study 32423392 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 540
Study 32423392 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental formula (EF)
Number of subjects: 540
Study 36259713 — intervention group
Group type: EXPERIMENTAL
Intervention: RDN+AF ablation
Number of subjects: 61
Study 36259713 — intervention group
Group type: COMPARATOR
Intervention: AF-only ablation
Number of subjects: 61
Study 36259713 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 34187832 — intervention group
Group type: EXPERIMENTAL
Intervention: Seroprevalence of anti-SARS-CoV-2 antibodies
Number of subjects: 850
Study 34187832 — intervention group
Group type: EXPERIMENTAL
Intervention: Seroconversion during follow-up
Number of subjects: 850
Study 34187832 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralising antibodies
Number of subjects: 850
Study 34187832 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-qPCR results
Number of subjects: 850
Study 34187832 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19-compatible symptoms
Number of subjects: 850
Study 32042439 — intervention group
Group type: EXPERIMENTAL
Intervention: GENIE intervention
Number of subjects: 22
Study 32042439 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 22
Study 34850808 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesive zipper for 3 months after surgery
Number of subjects: 64
Study 34850808 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tissue adhesive zipper)
Number of subjects: 64
Study 34850808 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study 33619370 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ShA9
Number of subjects: 54
Study 33619370 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 54
Study 33799084 — intervention group
Group type: EXPERIMENTAL
Intervention: Group readiness assurance test
Number of subjects: 194
Study 32057470 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitised condylar retractor
Number of subjects: 48
Study 32057470 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgical instruments
Number of subjects: 48
Study 35039272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling blood detoxification decoction plus traditional Chinese medicine (TCM) care
Number of subjects: 120
Study 35039272 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment plus routine nursing
Number of subjects: 120
Study 34585780 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 5 mg dose of zoledronate
Number of subjects: 116
Study 34585780 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-yearly doses of 2.5 mg zoledronate
Number of subjects: 116
Study 34585780 — intervention group
Group type: EXPERIMENTAL
Intervention: Redosing with 1 mg zoledronate
Number of subjects: 116
Study 34585780 — intervention group
Group type: EXPERIMENTAL
Intervention: Redosing with 2.5 mg zoledronate
Number of subjects: 116
Study 34585780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 33940213 — intervention group
Group type: COMPARATOR
Intervention: Maintaining low-dose ICS/LABA (G1)
Number of subjects: 225
Study 33940213 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuing LABA (G2)
Number of subjects: 225
Study 33940213 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing ICS/LABA to once daily (G3)
Number of subjects: 225
Study 32089025 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling based on Gamble's approach (3 sessions before delivery and 1 session postpartum)
Number of subjects: 60
Study 32089025 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care (Control)
Number of subjects: 60
Study 33407787 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory repetitive transcranial magnetic stimulation (r-TMS) applied over the left intact parietal cortex followed by visual scanning treatment
Number of subjects: 0
Study 33407787 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation (SHAM control) followed by visual scanning treatment
Number of subjects: 0
Study 32891284 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil
Number of subjects: 129
Study 32891284 — intervention group
Group type: COMPARATOR
Intervention: Control (no extra virgin olive oil)
Number of subjects: 129
Study 35769675 — intervention group
Group type: EXPERIMENTAL
Intervention: Grandioseal, Voco, Germany
Number of subjects: 50
Study 35769675 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartseal & Loc, Detax Gmbh & Co, Germany
Number of subjects: 50
Study 35769675 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuji triage capsule, GC, Belgium
Number of subjects: 50
Study 35769675 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study 34431611 — intervention group
Group type: EXPERIMENTAL
Intervention: Food addiction framing
Number of subjects: 447
Study 34431611 — intervention group
Group type: COMPARATOR
Intervention: Control passage about memory
Number of subjects: 447
Study 34431611 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating addiction framing
Number of subjects: 447
Study 34431611 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie balance explanations for obesity
Number of subjects: 447
Study 35604035 — intervention group
Group type: COMPARATOR
Intervention: Adhesive applied according to the manufacturers' recommendations (control group)
Number of subjects: 39
Study 35604035 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubling the adhesive application time
Number of subjects: 39
Study 35604035 — intervention group
Group type: EXPERIMENTAL
Intervention: Applying double adhesive layers
Number of subjects: 39
Study 33534199 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine (LDX)
Number of subjects: 23
Study 34904623 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV vaccine
Number of subjects: 0
Study 34904623 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatments
Number of subjects: 0
Study 32070681 — intervention group
Group type: EXPERIMENTAL
Intervention: ART-Def (initiating ART following immunological or clinical deterioration)
Number of subjects: 0